1. Home
  2. OEC vs CUVL Comparison

OEC vs CUVL Comparison

Compare OEC & CUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion S.A.

OEC

Orion S.A.

HOLD

Current Price

$5.90

Market Cap

397.0M

Sector

Industrials

ML Signal

HOLD

Logo Clinuvel Pharmaceuticals Limited American Depositary Shares

CUVL

Clinuvel Pharmaceuticals Limited American Depositary Shares

N/A

Current Price

$5.63

Market Cap

374.2M

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
OEC
CUVL
Founded
1862
N/A
Country
Luxembourg
Australia
Employees
N/A
16
Industry
Major Chemicals
Miscellaneous
Sector
Industrials
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
397.0M
374.2M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
OEC
CUVL
Price
$5.90
$5.63
Analyst Decision
Sell
Analyst Count
4
0
Target Price
★ $6.56
N/A
AVG Volume (30 Days)
★ 344.7K
22.8K
Earning Date
05-06-2026
N/A
Dividend Yield
★ 1.11%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,806,700,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.21
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.35
$5.70
52 Week High
$8.64
$8.20

Technical Indicators

Market Signals
Indicator
OEC
CUVL
Relative Strength Index (RSI) 45.19 34.38
Support Level $5.61 N/A
Resistance Level $6.57 $6.07
Average True Range (ATR) 0.25 0.16
MACD 0.04 -0.01
Stochastic Oscillator 44.06 3.39

Price Performance

Historical Comparison
OEC
CUVL

About OEC Orion S.A.

Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical, and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. The Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.

About CUVL Clinuvel Pharmaceuticals Limited American Depositary Shares

Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.

Share on Social Networks: